Photo-triggered release of active substances from dendrimer-photosensitizer complexes
AssigneeCeramOptec Industries, Inc.
InventorsVolker Albrecht, Arno Wiehe, Beate Roeder, Wolfgang Neuberger
Life of this patent
Estimating the term…
Loading patent…
AssigneeCeramOptec Industries, Inc.
InventorsVolker Albrecht, Arno Wiehe, Beate Roeder, Wolfgang Neuberger
Estimating the term…
Compositions of dendrimer-photosensitizer complexes including therapeutic molecules, and methods for their synthesis and use are disclosed. The therapeutic molecules and the photosensitizers are each covalently attached to the dendrimer at its end-groups, essentially randomly. Upon exposure to radiation of a suitable wavelength, the photosensitizers are activated to break up the dendrimer structure and thus release the therapeutic molecules. In a preferred embodiment, the end-groups of the dendrimer are replaced with or covalently connected to therapeutic molecules and photosensitizers. In a further preferred embodiment, targeting molecules may also be attached to the dendrimer to create a more accurate treatment. The present invention is especially useful for medical applications, where therapeutic molecules can be delivered to body areas for treatment of a variety of diseases without risk of premature release in the body, due to the strength and stability of the bonds between the end-groups and the photosensitizers and therapeutic molecules.
A therapeutic molecule delivery complex, comprising:
Dependencies are inferred from the claim text.